Dechert served as legal counsel to Aquestive Therapeutics, Inc., while Cooley acted for the underwriters on the offering.Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”),…
Aquestive Therapeutics’ $75 Million Common Stock Offering
